Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
Healthy Volunteers
NCT06911697

Study on c-Met Targeted PET/CT Imaging in NSCLC

Led by Xilin Sun · Updated on 2025-04-04

88

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

Sponsors

X

Xilin Sun

Lead Sponsor

H

Henan Provincial People's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators developed a 18F labeled small molecule, 18F-TSPF, based on c-Met TKI, as a targeted molecular imaging agent for noninvasive and repeatable detecting c-Met activation status.

CONDITIONS

Official Title

Study on c-Met Targeted PET/CT Imaging in NSCLC

Who Can Participate

Age: 18Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age range 18-75 years, open to both male and female participants
  • Normal hepatic, renal, and cardiac function
  • Expected survival of at least 12 weeks
  • Good adherence to follow-up
  • Presence of at least one measurable target lesion according to RECIST 1.1 criteria
  • Women of childbearing age must have a negative pregnancy test within 7 days before the study and agree to use effective contraception during the study and for 3 months after
  • Patients recommended by a clinical physician for PET/CT scans for tumor diagnosis and staging
  • Participants must understand the study and voluntarily agree to participate by signing informed consent
Not Eligible

You will not qualify if you...

  • Severe abnormalities in liver and renal function and blood counts
  • Patients planning to conceive
  • Pregnant or lactating women
  • Individuals unable to lie flat for thirty minutes
  • Individuals who refuse to participate in the clinical study
  • Individuals with claustrophobia or other psychiatric disorders
  • Other situations deemed unsuitable for trial participation by the researchers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Nuclear Medicine, Fourth Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China, 150028

Actively Recruiting

Loading map...

Research Team

X

Xilin Sun, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study on c-Met Targeted PET/CT Imaging in NSCLC | DecenTrialz